Ramsay Health Care shares (ASX: RHC) sat atop the ASX 200 leaderboard today, adding 13.72% to reclaim the psychological handle at A$50.06 today. This marks the first time in more than two years that bulls have flipped A$50, smashing through the stock’s prior 52-week high of A$45.62 in a decisive move. The company’s full-year result, released Thursday morning gave bulls the green light to push on, with an intraday and multi year high of A$51.10 the new watermark to watch.
Looking to the print, the company put out NPAT figures of $364.1million for a 22.9% Y/Y increase, as underlying EPS grew 27% to $1.51. This came on a revenue growth of 4.2%, demonstrating the scale of margin improvement that warranted a bounce in the market.
Supported by a final fully franked dividend of 48.5cents per share (91 cents total) and there was already plenty to like, before the guide came through. That guidance suggested more of the same in FY27, with managements pointing to further margin improvements, and a continued focus on capital discipline and cost management.
The move in the RHC share price is all the more impressive having taken place at a clear resistance level at A$45 that had capped earlier attempts. The market was already leaning bullish, and with holders now looking at gains of 44.72% YTD, at least some of the decline from recent years can be put to bed. Zooming out to the 5 year chart makes the picture cleaner, with the stock down 26.61% on the period, yet bouncing towards another key point of friction at A$50.
There are possibly some holders from back in 2024 who would want to see the back of the stock now that it has regained the earlier lost ground, although there will be many more looking back for clues as to the next upside levels to watch. It is unlikely to be a quiet lull into the weekend when trading resumes with this kind of setup.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
Technical Setup
The trend structure itself is constructive, with the price above the 50-day average at A$43.37, and the 200-day at A$38.83. The 20-day EMA at A$44.29 also remains above the 50-day equivalent at A$43.17. The caution now comes from how far the move has stretched. The RSI has moved to 78.68 on the day, a level considered to be technically overbought, although during periods of fundamental updates, elevated levels can hold for longer than might usually be the case.
The share price closed above the upper Bollinger Band at A$45.37, meaning it is trading outside its recent volatility envelope with a band width of only 3.88%. Meanwhile, the ADX reading of about 31 shows genuine trend strength, but its falling profile suggests the trend may be past its peak intensity, consistent with a mature move where marginal buyers are pushing the price faster than the underlying trend is strengthening.
Prior analysis had Ramsay on a trailing earnings multiple in the mid-to-high 30s, with net margins around 1.5%, return on equity in the 5% to 6% region, and a debt-to-equity ratio north of 230%. None of that is disqualifying on its own, but it frames the investment case as a bet on stability and structural demand rather than exceptional returns on capital. At A$50.06, the market is paying for sustained execution and benign conditions, with a PE of 42.
Volume today of 2.51million shares, some 4.05x the ADV points to plenty of interest in the stock from here, and with bulls seeking a strong hold of A$50, and bears targeting a break below, the final trading session of the week is likely to be an interesting watch.
